Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A retrospective analysis of treatment and retention outcomes of pregnant and/or parenting women with opioid use disorder.

Lopian KM, Chebolu E, Kulak JA, Kahn LS, Blondell RD.

J Subst Abuse Treat. 2019 Feb;97:1-6. doi: 10.1016/j.jsat.2018.11.002. Epub 2018 Nov 10.

PMID:
30577894
2.

Extracting Deep Phenotypes for Chronic Kidney Disease Using Electronic Health Records.

Luong DTA, Tran D, Pace WD, Dickinson M, Vassalotti J, Carroll J, Withiam-Leitch M, Yang M, Satchidanand N, Staton E, Kahn LS, Chandola V, Fox CH.

EGEMS (Wash DC). 2017 Jun 12;5(1):9. doi: 10.5334/egems.226.

3.

A parenting education program for women in treatment for opioid-use disorder at an outpatient medical practice.

Kahn LS, Mendel WE Msw PhD, Fallin KL Msw, Borngraber EA Msw, Nochajski TH, Rea WE Mba Lmsw, Blondell RD Md.

Soc Work Health Care. 2017 Aug;56(7):649-665. doi: 10.1080/00981389.2017.1327470. Epub 2017 Jun 8.

PMID:
28594601
4.

Nurse perspectives on the implementation of routine telemonitoring for high-risk diabetes patients in a primary care setting.

Vest BM, Hall VM, Kahn LS, Heider AR, Maloney N, Singh R.

Prim Health Care Res Dev. 2017 Jan;18(1):3-13. Epub 2016 Jun 8.

PMID:
27269513
5.

Developing a Smoking Cessation Intervention for Low Income and Minority Women.

duPont NC, Mahoney MC, Kahn LS, Vest BM, Widman CA, Clark-Hargrave NS, Erwin DO.

J Womens Health Care. 2016 Apr;5(2). pii: 309. doi: 10.4172/2167-0420.1000309. Epub 2016 Apr 25.

6.

Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD Study.

Vest BM, York TR, Sand J, Fox CH, Kahn LS.

J Am Board Fam Med. 2015 Sep-Oct;28(5):624-31. doi: 10.3122/jabfm.2015.05.150070.

7.

"Living well with diabetes": evaluation of a pilot program to promote diabetes prevention and self-management in a medically underserved community.

Cadzow RB, Vest BM, Craig M, Rowe JS, Kahn LS.

Diabetes Spectr. 2014 Nov;27(4):246-55. doi: 10.2337/diaspect.27.4.246.

8.

Chronic kidney disease (CKD) treatment burden among low-income primary care patients.

Kahn LS, Vest BM, Madurai N, Singh R, York TR, Cipparone CW, Reilly S, Malik KS, Fox CH.

Chronic Illn. 2015 Sep;11(3):171-83. doi: 10.1177/1742395314559751. Epub 2014 Nov 21.

9.

Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD).

Fox CH, Vest BM, Kahn LS, Dickinson LM, Fang H, Pace W, Kimminau K, Vassalotti J, Loskutova N, Peterson K.

Implement Sci. 2013 Aug 8;8:88. doi: 10.1186/1748-5908-8-88.

10.

Diabetes self-management in a low-income population: impacts of social support and relationships with the health care system.

Vest BM, Kahn LS, Danzo A, Tumiel-Berhalter L, Schuster RC, Karl R, Taylor R, Glaser K, Danakas A, Fox CH.

Chronic Illn. 2013 Jun;9(2):145-55. doi: 10.1177/1742395313475674. Epub 2013 Apr 12.

11.

A community-academic partnership to adapt a curriculum for people with serious mental illnesses and diabetes.

Kahn LS, Pastore PA, Rodriguez EM, Tumiel-Berhalter L, Kelley M, Bartlett DP, Saunders EA, Fox CH.

Prog Community Health Partnersh. 2012 Winter;6(4):443-50. doi: 10.1353/cpr.2012.0060.

PMID:
23221289
12.

Transforming community members into diabetes cultural health brokers: the Neighborhood Health Talker project.

Cadzow RB, Craig M, Rowe J, Kahn LS.

Diabetes Educ. 2013 Jan-Feb;39(1):100-8. doi: 10.1177/0145721712465342. Epub 2012 Nov 13.

PMID:
23150528
13.

A decade after the KDOQI CKD guidelines: impact on primary care.

Fox CH, Kahn LS, Vassalotti J.

Am J Kidney Dis. 2012 Nov;60(5):707-9. doi: 10.1053/j.ajkd.2012.08.024. No abstract available.

PMID:
23067636
14.

Living with diabetes on Buffalo, New York's culturally diverse West Side.

Kahn LS, Vest BM, Karl R, Tumiel-Berhalter L, Taylor R, Schuster RC, Glaser K, Danakas A, Fox CH.

Chronic Illn. 2013 Mar;9(1):43-56. doi: 10.1177/1742395312450895. Epub 2012 Jun 7.

15.

The impacts of "growing our own": a pilot project to address health disparities by training health professionals to become certified diabetes educators in safety net practices.

Kahn LS, Tumiel-Berhalter L, D'Aniello R, Danzo A, Fox CH, Taylor J, Holland S, Glaser K, Patel V, Glick M.

Diabetes Educ. 2012 Jan-Feb;38(1):86-93. doi: 10.1177/0145721711427455. Epub 2011 Dec 6.

PMID:
22146787
16.

High prevalence of undetected vitamin D deficiency in an urban minority primary care practice.

Kahn LS, Satchidanand N, Kopparapu A, Goh W, Yale S, Fox CH.

J Natl Med Assoc. 2011 May;103(5):407-11.

PMID:
21809790
17.

Fasting Blood Glucose and Depressive Mood among Patients with Mental Illness in a Medicaid Managed Care Program.

Kahn LS, McIntyre RS, Rafalson L, Berdine DE, Fox CH.

Depress Res Treat. 2011;2011:862708. doi: 10.1155/2011/862708. Epub 2011 May 26.

18.

Diabetes educators in safety-net practices: a qualitative study.

Kahn LS, Glaser K, Fox CH, Patterson A.

Diabetes Educ. 2011 Mar-Apr;37(2):212-9. doi: 10.1177/0145721710397385. Epub 2011 Feb 28.

PMID:
21357750
19.

Two years after a quality improvement intervention for chronic kidney disease care in a primary care office.

Wentworth AL, Fox CH, Kahn LS, Glaser K, Cadzow R.

Am J Med Qual. 2011 May-Jun;26(3):200-5. doi: 10.1177/1062860610381916. Epub 2010 Oct 8.

PMID:
20935276
20.

Bipolar disorder and metabolic syndrome: an international perspective.

McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HT, Kahn LS, Kucyi A, Soczynska JK, Woldeyohannes HO, Lachowski A, Kim B, Nathanson J, Alsuwaidan M, Taylor VH.

J Affect Disord. 2010 Nov;126(3):366-87. doi: 10.1016/j.jad.2010.04.012. Epub 2010 Jun 12. Review.

PMID:
20541810
21.

Telephonic nurse case management for patients with diabetes and mental illnesses: a qualitative perspective.

Kahn LS, Fox CH, Carrington J, Desai U, Bartlett DP, Lyle H, Kowalski M.

Chronic Illn. 2009 Dec;5(4):257-67. doi: 10.1177/1742395309350229.

PMID:
20156943
22.

The use of telephonic case management to link a special-needs population with a primary care physician.

Kahn LS, Aiello J, Berdine DE, Fox CH.

J Am Board Fam Med. 2009 Sep-Oct;22(5):585-7. doi: 10.3122/jabfm.2009.05.080230.

23.

Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap.

McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH, Woldeyohannes HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn LS, Goldstein BI.

Curr Diab Rep. 2009 Feb;9(1):51-9. Review.

PMID:
19192425
24.

Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.

Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM.

J Am Board Fam Med. 2008 Nov-Dec;21(6):522-30. doi: 10.3122/jabfm.2008.06.080042.

25.

Assessing the prevalence of depression among individuals with diabetes in a Medicaid managed-care program.

Kahn LS, Fox CH, McIntyre RS, Tumiel-Berhalter L, Berdine DE, Lyle H.

Int J Psychiatry Med. 2008;38(1):13-29.

PMID:
18624014
26.

Adolescent substance use and abuse: recognition and management.

Griswold KS, Aronoff H, Kernan JB, Kahn LS.

Am Fam Physician. 2008 Feb 1;77(3):331-6. Review.

27.

An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes.

Cramer JS, Sibley RF, Bartlett DP, Kahn LS, Loffredo L.

Diabetes Educ. 2007 May-Jun;33(3):503-8.

PMID:
17570881
28.

A physician self-assessment tool for quality improvement.

Kahn LS, Fox CH, Berdine DE, Krause-Kelly J, Raghu V.

J Healthc Qual. 2007 Mar-Apr;29(2):38-43.

PMID:
17465169
29.

Facilitating quality improvement in physician management of comorbid chronic disease in an urban minority practice.

Kahn LS, Fox CH, Olawaiye A, Servoss TJ, McLean-Plunkett E.

J Natl Med Assoc. 2007 Apr;99(4):377-83.

30.

The impacts of subsidized health insurance on employees' use of preventive health services.

Kahn LS, Tumiel-Berhalter L, Cadzow R, Watkins R, Leonard KM, Taylor JS.

Eval Health Prof. 2007 Mar;30(1):22-34.

PMID:
17293606
31.

Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes?

Halbreich U, Kahn LS.

J Affect Disord. 2007 Sep;102(1-3):245-58. Epub 2006 Nov 7. Review.

PMID:
17092565
32.
33.

Nursing recruitment and retention in New York state: a qualitative workforce needs assessment.

Brewer CS, Zayas LE, Kahn LS, Sienkiewicz MJ.

Policy Polit Nurs Pract. 2006 Feb;7(1):54-63. Erratum in: Policy Polit Nurs Pract. 2006 May;7(2):151.

PMID:
16682374
34.

Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects.

Halbreich U, Kahn LS.

J Psychiatr Pract. 2003 Sep;9(5):344-53.

PMID:
15985953
35.

Screening for mental illness in primary care clinics.

Kahn LS, Halbreich U, Bloom MS, Bidani R, Rich E, Hershey CO.

Int J Psychiatry Med. 2004;34(4):345-62.

PMID:
15825584
36.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
37.

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Halbreich U, Borenstein J, Pearlstein T, Kahn LS.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:1-23. Review.

PMID:
12892987
38.

Hormonal aspects of schizophrenias: an overview.

Halbreich U, Kahn LS.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:1-16. Review.

PMID:
12650679
39.

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.

Halbreich U, Kinon BJ, Gilmore JA, Kahn LS.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:53-67. Review.

PMID:
12504072
40.

Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices.

Mitwally MF, Kahn LS, Halbreich U.

Expert Opin Pharmacother. 2002 Nov;3(11):1577-90. Review.

PMID:
12437492
41.

Role of estrogen in the aetiology and treatment of mood disorders.

Halbreich U, Kahn LS.

CNS Drugs. 2001;15(10):797-817. Review.

PMID:
11602005
42.

Oral contraceptives and mood.

Kahn LS, Halbreich U.

Expert Opin Pharmacother. 2001 Sep;2(9):1367-82. Review.

PMID:
11585017
43.

Are women with premenstrual dysphoric disorder prone to osteoporosis?

Halbreich U, Kahn LS.

Psychosom Med. 2001 May-Jun;63(3):361-4.

PMID:
11382263
44.

Selective oestrogen receptor modulators--current and future brain and behaviour applications.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2000 Dec;1(7):1385-98. Review.

PMID:
11249472
45.

Serum immunoglobulins and uveitis.

Kahn LS, Schlaegel TF Jr, Weber JC, Biegel A.

Arch Ophthalmol. 1983 Mar;101(3):458-9.

PMID:
6830503

Supplemental Content

Support Center